Pmda - Pharmaceuticals and Medical Devices Agency

Jump to body

Navigation of each product type

Our recommended contents

Navigation of each product type

Our recommended contents

Here begins the text.

Public comments(Japanese Pharmacopoeia)

Open public comments

New/Update	Posted month	Title	Period
	June, 2020	JP Drafts (June 2020)	June 5, 2020 - August 31, 2020

Closed public comments

New/Update	Posted month	Title	Period
	March, 2020	JP Drafts (March 2020) No.2	March 6, 2020 - May 31, 2020

Public comments(Japanese Pharmacopoeia)(Fiscal year 2019)

Public comments(Japanese Pharmacopoeia)(Fiscal year 2018)

Public comments(Japanese Pharmacopoeia)(Fiscal year 2017)

Public comments(Japanese Pharmacopoeia)(Fiscal year 2016)

Regulatory Science/The Science Board/Standard Development

Regulatory Science
The Science Board
- Outline
- The Science Board
- Outcome Documents of the Science Board
- Subcommittees (2019 December-)
  - Subcommittee on Computer Simulation
- The Fourth Term Subcommittees (-2019 November)
  - Subcommittee on AMR
  - Subcommittee on Genome Editing
- The Third Term (- 2018 March) Subcommittees
  - Subcommittee on Rare Cancers
  - Subcommittee on Pharmaceuticals Development
  - Subcommittee on AI (Artificial Intelligence)
- The Second Term (- 2016 March) Subcommittees
- The First Term (- 2014 March) Subcommittees
  - Pharmaceuticals Subcommittee
  - Medical Devices Subcommittee
  - Bio-products Subcommittee
  - Cellular and Tissue-based Products Subcommittee
Standard Development
- Outline
- Japanese Pharmacopoeia
- Medical Device Standards

Pmda - Pharmaceuticals and Medical Devices Agency

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.